GBp 14.5
(-3.33%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.16 Million | -1.53 Million | -1.34 Million | -881.33 Thousand | -959.74 Thousand | -653.83 Thousand |
Net Income | -2.86 Million | -2.04 Million | -1.48 Million | -1.29 Million | -428.7 Thousand | -1.37 Million |
Depreciation & Amortization | 72.75 Thousand | 52.77 Thousand | 42.42 Thousand | 41.38 Thousand | 25.58 Thousand | 14.69 Thousand |
Deferred income taxes | -84.5 Thousand | - | 324 Thousand | -2806.00 | 10.72 Thousand | 591.33 Thousand |
Stock-based compensation | 387.66 Thousand | 240.53 Thousand | 23.33 Thousand | 2806.00 | 130.13 Thousand | 196.46 Thousand |
Change in working capital | -216 Thousand | -80.36 Thousand | -187.52 Thousand | 95.42 Thousand | -91.07 Thousand | -70.13 Thousand |
Other non-cash items | 929.62 Thousand | 290.19 Thousand | -66.4 Thousand | 276.55 Thousand | -606.39 Thousand | -11.6 Thousand |
Investing Cash Flow | -2.25 Million | -1.5 Million | -773.15 Thousand | -645.54 Thousand | -1.34 Million | -827.18 Thousand |
Investments in PPE | -2.34 Million | -1.57 Million | -822.06 Thousand | -711.93 Thousand | -1.38 Million | -781.01 Thousand |
Acquisitions | - | - | 24.8 Thousand | 40 Thousand | 30.03 Thousand | -250 Thousand |
Investment purchases | - | - | - | - | 1.3 Million | 778.49 Thousand |
Sales/Maturities of investments | - | 21.95 Thousand | - | - | 7.00 | 13.00 |
Other Investing Activities | 96.75 Thousand | 45.12 Thousand | 24.1 Thousand | 26.39 Thousand | -1.29 Million | -574.68 Thousand |
Financing Cash Flow | 3.64 Million | 1.54 Million | 1.4 Million | 4.66 Million | 1.9 Million | 1.42 Million |
Debt repayment | -23.20 | -1.55 Million | -5.59 | -953.11 Thousand | -4.47 | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 3.66 Million | - | 1.42 Million | 6 Million | 2 Million | 1.5 Million |
Other Financing Activities | 3666.05 | 3.1 Million | -24.61 Thousand | -390.45 Thousand | -98.18 Thousand | -75 Thousand |
Accounts receivables | 61.39 Thousand | -36.53 Thousand | -12.79 Thousand | -2203.00 | -106 Thousand | 2603.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -277.4 Thousand | -43.82 Thousand | -174.73 Thousand | 97.62 Thousand | 14.93 Thousand | -72.74 Thousand |
Cash at beginning of period | 1.77 Million | 3.33 Million | 4.32 Million | 1.12 Million | 1.53 Million | 1.58 Million |
Cash at end of period | 905.55 Thousand | 1.77 Million | 3.33 Million | 4.32 Million | 1.12 Million | 1.53 Million |
Capital Expenditure | -2.34 Million | -1.57 Million | -822.06 Thousand | -711.93 Thousand | -1.38 Million | -781.01 Thousand |
Effect of forex changes on cash | -102.22 Thousand | -65.04 Thousand | -273.16 Thousand | 69.42 Thousand | -5071.00 | -644.00 |
Net cash flow / Change in cash | -871 Thousand | -1.55 Million | -993.28 Thousand | 3.2 Million | -409.17 Thousand | -56.66 Thousand |
Free Cash Flow | -4.51 Million | -3.1 Million | -2.17 Million | -1.59 Million | -2.34 Million | -1.43 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -546.63 | -412.81 | -535.29 | -2.86 Million | -567.92 | -1017.31 |
Depreciation & Amortization | - | - | - | 72.75 Thousand | - | - |
Deferred income taxes | - | - | - | -84.5 Thousand | - | - |
Stock-based compensation | 116.28 | 10.82 | 24.31 | 387.66 Thousand | 124.51 | 158.12 |
Change in working capital | - | - | - | -216 Thousand | - | - |
Other non-cash items | 430.35 | 401.99 | 510.98 | 929.62 Thousand | 567.92 | 859.19 |
Investing Cash Flow | - | - | - | -2.25 Million | - | - |
Investments in PPE | - | - | - | -2.34 Million | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | 96.75 Thousand | - | - |
Financing Cash Flow | - | - | - | 3.64 Million | - | - |
Debt repayment | - | - | - | -23.20 | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 3.66 Million | - | - |
Other Financing Activities | - | - | - | 3666.05 | - | - |
Accounts receivables | - | - | - | 61.39 Thousand | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | -277.4 Thousand | - | - |
Cash at beginning of period | - | - | - | 1.77 Million | 2.85 Million | 4.33 Million |
Cash at end of period | - | - | - | 905.55 Thousand | 1.71 Million | 2.85 Million |
Capital Expenditure | - | - | - | -2.34 Million | - | - |
Effect of forex changes on cash | - | - | - | -102.22 Thousand | - | - |
Net cash flow / Change in cash | - | - | - | -871 Thousand | -1.13 Million | -1.48 Million |
Free Cash Flow | - | - | - | -4.51 Million | - | - |
CDLR
3803
IVP
DALBHARAT
VAXX
1851